Shareholders Equity: The sum of preferred and common equity items.
Seres Therapeutics, Inc. (MCRB) had Shareholders Equity of $26.50M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$0.36M |
|
$-19.91M |
|
-- |
|
$0.36M |
|
$21.27M |
|
$-20.91M |
|
$0.99M |
|
$-19.91M |
|
$-19.91M |
|
$-19.91M |
|
$-19.91M |
|
$-19.91M |
|
$-19.91M |
|
$-20.91M |
|
$-20.13M |
|
9.58M |
|
9.58M |
|
$-2.08 |
|
$-2.08 |
|
| Balance Sheet Financials | |
$31.84M |
|
$6.85M |
|
$85.78M |
|
$117.62M |
|
$19.34M |
|
-- |
|
$71.78M |
|
$91.12M |
|
$26.50M |
|
$26.50M |
|
|
Shareholders Equity |
$26.50M |
9.59M |
|
| Cash Flow Statement Financials | |
$-16.36M |
|
-- |
|
$0.43M |
|
$54.43M |
|
$38.50M |
|
$-15.93M |
|
$1.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.65 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-5839.94% |
|
-5839.94% |
|
-- |
|
-5562.29% |
|
-5562.29% |
|
$-16.36M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
1.54 |
|
58.58 |
|
-75.15% |
|
-75.15% |
|
-16.93% |
|
-75.15% |
|
$2.76 |
|
$-1.71 |
|
$-1.71 |
|